• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度药用植物来源的抗 SARS-CoV2 主蛋白酶化合物的抑制作用的结构基础。

Structural basis for the inhibition of SARS-CoV2 main protease by Indian medicinal plant-derived antiviral compounds.

机构信息

Center for High Performance Computing, Joint Engineering Research Center for Health Big Data Intelligent Analysis Technology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, PR China.

Department of Bioinformatics, Marudupandiyar College & Lysine Biotech Pvt Ltd, Thanjavur, Tamilnadu, India.

出版信息

J Biomol Struct Dyn. 2022 Mar;40(5):1970-1978. doi: 10.1080/07391102.2020.1834457. Epub 2020 Oct 19.

DOI:10.1080/07391102.2020.1834457
PMID:33073712
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7594188/
Abstract

A novel coronavirus (SARS-CoV2) has caused a major outbreak in humans around the globe, and it became a severe threat to human healthcare than all other infectious diseases. Researchers were urged to discover and test various approaches to control and prevent such a deadly disease. Considering the emergency and necessity, we screened reported antiviral compounds present in the traditional Indian medicinal plants for the inhibition of SARS-CoV2 main protease. In this study, we used molecular docking to screen 41 reported antiviral compounds that exist in Indian medicinal plants and shown amentoflavone from the plant with a higher docking score. Furthermore, we performed a 40 ns atomic molecular dynamics simulation and free binding energy calculations to explore the stability of the top five protein-ligand complexes. Through the article, we insist that the amentoflavone, hypericin and Torvoside H from the traditional Indian medicinal plants may be used as a potential inhibitor of SARS-CoV2 main protease and further biochemical experiments could shed light on understanding the mechanism of inhibition by these plant-derived antiviral compounds.Communicated by Ramaswamy H. Sarma.

摘要

一种新型冠状病毒(SARS-CoV2)在全球范围内引发了重大疫情,它对人类医疗保健的威胁超过了所有其他传染病。研究人员被敦促发现并测试各种方法来控制和预防这种致命疾病。考虑到紧急性和必要性,我们筛选了印度传统药用植物中报告的抗病毒化合物,以抑制 SARS-CoV2 主要蛋白酶。在这项研究中,我们使用分子对接筛选了 41 种存在于印度药用植物中的报告抗病毒化合物,其中来自植物的芹菜素表现出更高的对接分数。此外,我们进行了 40ns 的原子分子动力学模拟和自由结合能计算,以探索前五个蛋白-配体复合物的稳定性。通过本文,我们坚持认为传统印度药用植物中的芹菜素、金丝桃素和 Torvoside H 可能被用作 SARS-CoV2 主要蛋白酶的潜在抑制剂,进一步的生化实验可以阐明这些植物衍生的抗病毒化合物的抑制机制。由 Ramaswamy H. Sarma 交流。

相似文献

1
Structural basis for the inhibition of SARS-CoV2 main protease by Indian medicinal plant-derived antiviral compounds.印度药用植物来源的抗 SARS-CoV2 主蛋白酶化合物的抑制作用的结构基础。
J Biomol Struct Dyn. 2022 Mar;40(5):1970-1978. doi: 10.1080/07391102.2020.1834457. Epub 2020 Oct 19.
2
Computational identification of potential inhibitory compounds in Indian medicinal and aromatic plant species against major pathogenicity determinants of SARS-CoV-2.计算鉴定印度药用和芳香植物物种中针对 SARS-CoV-2 主要致病性决定因素的潜在抑制化合物。
J Biomol Struct Dyn. 2022;40(24):14096-14114. doi: 10.1080/07391102.2021.2000500. Epub 2021 Nov 12.
3
In Silico Evaluation of Iranian Medicinal Plant Phytoconstituents as Inhibitors against Main Protease and the Receptor-Binding Domain of SARS-CoV-2.基于计算机的伊朗药用植物植物成分对 SARS-CoV-2 主要蛋白酶和受体结合域抑制作用的评估。
Molecules. 2021 Sep 21;26(18):5724. doi: 10.3390/molecules26185724.
4
Synthetic flavonoids as potential antiviral agents against SARS-CoV-2 main protease.合成类黄酮作为抗 SARS-CoV-2 主蛋白酶的潜在抗病毒药物。
J Biomol Struct Dyn. 2022 May;40(8):3777-3788. doi: 10.1080/07391102.2020.1850359. Epub 2020 Nov 30.
5
Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants - (Ashwagandha), (Giloy) and (Tulsi) - a molecular docking study.通过阿育吠陀药用植物( Ashwagandha )、( Giloy )和( Tulsi )的活性植物化学成分靶向 COVID-19 ( SARS-CoV-2 )主蛋白酶 - ( Ashwagandha )、( Giloy )和( Tulsi ) - 分子对接研究。
J Biomol Struct Dyn. 2022 Jan;40(1):190-203. doi: 10.1080/07391102.2020.1810778. Epub 2020 Aug 27.
6
Identification of structural scaffold from interbioscreen (IBS) database to inhibit 3CLpro, PLpro, and RdRp of SARS-CoV-2 using molecular docking and dynamic simulation studies.利用分子对接和动力学模拟研究,从生物间筛选(IBS)数据库中鉴定出抑制严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的3C样蛋白酶(3CLpro)、木瓜蛋白酶样蛋白酶(PLpro)和RNA依赖性RNA聚合酶(RdRp)的结构支架。
J Biomol Struct Dyn. 2023;41(22):13168-13179. doi: 10.1080/07391102.2023.2175377. Epub 2023 Feb 9.
7
Investigating the novel acetonitrile derivatives as potential SARS-CoV-2 main protease inhibitor using molecular modeling approach.采用分子建模方法研究新型乙腈衍生物作为潜在的 SARS-CoV-2 主蛋白酶抑制剂。
J Biomol Struct Dyn. 2023 Jun;41(9):3943-3955. doi: 10.1080/07391102.2022.2059568. Epub 2022 Apr 6.
8
drug designing for COVID-19: an approach of high-throughput virtual screening, molecular, and essential dynamics simulations.用于 COVID-19 的药物设计:高通量虚拟筛选、分子和基本动力学模拟方法。
J Biomol Struct Dyn. 2022 Oct;40(16):7394-7407. doi: 10.1080/07391102.2021.1897681. Epub 2021 Mar 10.
9
identification and validation of natural antiviral compounds as potential inhibitors of SARS-CoV-2 methyltransferase.鉴定和验证天然抗病毒化合物作为 SARS-CoV-2 甲基转移酶潜在抑制剂的研究
J Biomol Struct Dyn. 2022 Sep;40(14):6534-6544. doi: 10.1080/07391102.2021.1886174. Epub 2021 Feb 15.
10
Investigation of berberine and its derivatives in Sars Cov-2 main protease structure by molecular docking, PROTOX-II and ADMET methods: in machine learning and in silico study.基于分子对接、PROTOX-II 和 ADMET 方法,运用机器学习和计算机模拟研究小檗碱及其衍生物对 SARS-CoV-2 主蛋白酶结构的影响
J Biomol Struct Dyn. 2023 Nov;41(19):9366-9381. doi: 10.1080/07391102.2022.2142848. Epub 2022 Nov 11.

引用本文的文献

1
Repurposing of Plant-based Antiviral Molecules for the Treatment of COVID-19.将植物源抗病毒分子重新用于治疗新冠肺炎
Curr Top Med Chem. 2024;24(7):614-633. doi: 10.2174/0115680266276749240206101847.
2
Evaluation of Potential Peptide-Based Inhibitors against SARS-CoV-2 and Variants of Concern.评估针对 SARS-CoV-2 及其关注变种的潜在基于肽的抑制剂。
Biomed Res Int. 2023 Oct 13;2023:3892370. doi: 10.1155/2023/3892370. eCollection 2023.
3
An Attention towards the Prophylactic and Therapeutic Options of Phytochemicals for SARS-CoV-2: A Molecular Insight.关注植物化学物质对 SARS-CoV-2 的预防和治疗选择:分子视角。
Molecules. 2023 Jan 13;28(2):795. doi: 10.3390/molecules28020795.
4
Susceptibility of SARS Coronavirus-2 infection in domestic and wild animals: a systematic review.家畜和野生动物对严重急性呼吸综合征冠状病毒2感染的易感性:一项系统综述。
3 Biotech. 2023 Jan;13(1):5. doi: 10.1007/s13205-022-03416-8. Epub 2022 Dec 11.
5
Evolutionary Aspects of Hypericin Productivity and Endogenous Phytohormone Pools Evidenced in Species In Vitro Culture Model.金丝桃素生产力和内源性植物激素库的进化方面在物种体外培养模型中的证据
Plants (Basel). 2022 Oct 18;11(20):2753. doi: 10.3390/plants11202753.
6
The Main Protease of SARS-CoV-2 as a Target for Phytochemicals against Coronavirus.新型冠状病毒主要蛋白酶作为植物化学物质抗冠状病毒的靶点
Plants (Basel). 2022 Jul 17;11(14):1862. doi: 10.3390/plants11141862.
7
Hybrid drug-screening strategy identifies potential SARS-CoV-2 cell-entry inhibitors targeting human transmembrane serine protease.混合药物筛选策略鉴定出靶向人跨膜丝氨酸蛋白酶的潜在新冠病毒细胞进入抑制剂。
Struct Chem. 2022;33(5):1503-1515. doi: 10.1007/s11224-022-01960-w. Epub 2022 May 11.
8
Molecular and structural insights of β-boswellic acid and glycyrrhizic acid as potent SARS-CoV-2 Envelope protein inhibitors.β-乳香酸和甘草酸作为强效严重急性呼吸综合征冠状病毒2包膜蛋白抑制剂的分子和结构见解
Phytomed Plus. 2022 May;2(2):100241. doi: 10.1016/j.phyplu.2022.100241. Epub 2022 Feb 12.
9
Insights Into Amentoflavone: A Natural Multifunctional Biflavonoid.杨梅素研究进展:一种天然多功能双黄酮类化合物。
Front Pharmacol. 2021 Dec 22;12:768708. doi: 10.3389/fphar.2021.768708. eCollection 2021.
10
Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PL and M/ 3CL: molecular docking and simulation studies of three pertinent medicinal plant natural components.严重急性呼吸综合征冠状病毒2(COVID-19)蛋白酶PL和M/3CL的潜在抑制剂:三种相关药用植物天然成分的分子对接和模拟研究
Curr Res Pharmacol Drug Discov. 2021;2:100038. doi: 10.1016/j.crphar.2021.100038. Epub 2021 Jun 5.